PURPOSE To evaluate the possible association between Covid-19 infection and subacute thyroiditis. METHODS We reviewed the medical and imaging records of patients referred to our Department's outpatient setting dedicated to 'thyroid emergency' (records with a 'bollino verde'-green sticker, classifed as urgent) from April 2020 to October 2020. This outpatient clinic is devoted to patients requiring evaluation for severe hypothyroidism, thyrotoxicosis and neck discomfort or pain. All patients with a newly-diagnosed subacute thyroiditis were selected. The data of all patients receiving a diagnosis of subacute thyroiditis was collected retrospectively, taking into account the same period of time (April-October) and starting from 2016. RESULTS During the COVID-19 outbreak in our region (April 2020 to October 2020) 396 patients attended the outpatient emergency clinic. Among them, 10 (2.5%) patients received a diagnosis of subacute thyroiditis. In a single patient, a 44-year-old man, a COVID-19 pulmonary infection had been diagnosed 7 weeks before the diagnosis of subacute thyroiditis. All of the remaining patients were and remain COVID-19 free as confirmed by telephone interview. The percentage of patients who received a diagnosis of subacute thyroiditis in the same period starting from 2016 was very similar (2.9%, 2.9%, 2.6% and 3.0% in 2016, 2017, 2018 and 2019, respectively). CONCLUSIONS Our data do not show an increase in the incidence of subacute thyroiditis in the Brescia area, a region with the highest prevalence of COVID-19 in Italy during the period of the pandemic outbreak.

中文翻译：

---

在 COVID-19 大流行期间，受 Sars-CoV-2 感染严重影响的地区发生 De Quervain 甲状腺炎。

目的 评估 Covid-19 感染与亚急性甲状腺炎之间可能存在的关联。方法 我们审查了 2020 年 4 月至 2020 年 10 月转诊至我科门诊的“甲状腺急诊”患者的医疗和影像记录（带有“bollino verde”绿色标签的记录，分类为紧急）。适用于需要评估严重甲状腺功能减退、甲状腺毒症和颈部不适或疼痛的患者。选择所有新诊断的亚急性​​甲状腺炎患者。回顾性收集所有接受亚急性甲状腺炎诊断的患者的数据，考虑到同一时间段（4-10月），从2016年开始。结果 在我们地区 COVID-19 爆发期间（2020 年 4 月至 2020 年 10 月），396 名患者就诊于急诊门诊。其中，10例（2.5%）患者被诊断为亚急性甲状腺炎。在一名 44 岁的男性患者中，在亚急性甲状腺炎诊断前 7 周被诊断为 COVID-19 肺部感染。电话采访证实，其余所有患者均未感染 COVID-19。从 2016 年开始，同期被诊断为亚急性甲状腺炎的患者比例非常相似（2016 年、2017 年、2018 年和 2019 年分别为 2.9%、2.9%、2.6% 和 3.0%）。结论 我们的数据并未显示布雷西亚地区亚急性甲状腺炎的发病率增加，